The following Structured Product Label (SPL) was submitted to the FDA by Advagen Pharma Limited for the product Loratadine (NDC 72888-029). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Loratadine Orally Disintegrating Tablets USP 10 mg - 10 Tablets - NDC 72888-029-09
Loratadine-odt-usp-10mg-10count (Loratadine Odt Usp 10mg 10count)
Loratadine Orally Disintegrating Tablets USP 10 mg - 30 Tablets - NDC 72888-029-11
Loratadine-odt-usp-10mg-30count (Loratadine Odt Usp 10mg 30count)
* Please review the disclaimer below.
